4.1 Review

Prognostic factors in diffuse leptomeningeal glioneuronal tumor (DLGNT): a systematic review

Journal

CHILDS NERVOUS SYSTEM
Volume 38, Issue 9, Pages 1663-1673

Publisher

SPRINGER
DOI: 10.1007/s00381-022-05600-w

Keywords

Diffuse leptomeningeal glioneuronal tumor (DLGNT); Predictors; Brain tumor; Risk factors; Survival

Funding

  1. Polish National Agency for Academic Exchange (the Walczak Programme)

Ask authors/readers for more resources

Diffuse leptomeningeal glioneuronal tumor (DLGNT) is a rare tumor with challenging diagnosis and prognosis. This systematic review identified Ki-67 ≥ 7% as the most important prognostic factor for overall survival (OS) in DLGNT patients, while symptoms of elevated intracranial pressure, age, and the presence of contrast-enhancing intraparenchymal tumor were also associated with poor OS.
Background Diffuse leptomeningeal glioneuronal tumor (DLGNT) is a rare tumor, first described by the WHO Classification of Central Nervous System Tumors in 2016. The clinical course is variable. Most tumors have low-grade histological findings although some may have more aggressive features. The goal of this systematic review was to identify prognostic factors for poor overall survival (OS). Material and methods We performed a systematic review using three databases (PubMed, Google Scholar, and Embase) and the following search terms: diffuse leptomeningeal glioneuronal tumor, DLGNT, DLMGNT. Statistical analysis was performed using Statistica 13.3. Results We included 34 reports in our review comprising 63 patients, published from 2016 to 2022. The median OS was 19 months (range: 12-51 months). Using multivariable Cox survival analysis, we showed that Ki-67 >= 7%, age > 9 years, symptoms of elevated intracranial pressure (ICP) at admission, and the presence of contrast-enhancing intraparenchymal tumor are associated with poor OS. Receiver operating characteristic (ROC) analysis identified Ki-67 >= 7% as a significant predictor of poor OS. Conclusions Signs or symptoms of increased ICP with imaging findings of diffuse leptomeningeal enhancement should raise suspicion for DLGNT. In our systematic review, Ki-67 >= 7% was the most important prognostic factor for OS in DLGNT. The presence of intraparenchymal tumor with contrast enhancement was thought to represent disease progression and, together with patient age, was associated with poor OS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available